The Healthy Muse
A breakthrough, promising vaccine development from Moderna, Teladoc's unprecedented surge, and an end to surprise billing? This week's top #healthcare news.

This week’s top healthcare news.

the promising vaccine edition - the healthy muse

the promising vaccine edition - the Healthy Muse

Coronavirus need to know’s

The latest numbers: 1,535,123 infected; 91,306 deaths in the U.S. 4,713,620 infected; 315,185 deaths globally. (View more data)

A promising vaccine result: Moderna, a large biotech firm, reported very promising results from its phase-1 clinical trial for a coronavirus vaccine.

  • After receiving 2 doses, most patients had antibody levels similar to those who have already recovered from the disease, and importantly, no safety concerns. The company will start Phase 3 trials in July, where the positive trend hopefully continues.

Vaccines and treatments errwhere: over 100 vaccines are in development globally, and 8 are in/starting human trials.

  • Don’t forget about non-vaccine treatments, too. The WHO is cautiously optimistic regarding potential treatments after positive data was released.
  • And don’t forget about Gilead’s remdesivir either, which is already being distributed. Read this interesting piece from Bloomberg on how the biotech giant prepared and was ready to meet the COVID-19 challenge

Opening up: Officials like Anthony Fauci are cautioning states against easing virus restrictions too quickly, thinking that the easing policies will cause unnecessary deaths.

New models: Interestingly, many independent viral prediction models are now converging.

  • NPR reports that most of these models are predicting 110,000 deaths by June.

Other ‘Rona Reads.

  • In a rare mission within the U.S., Doctors Without Borders sent a team to the Navajo Nation.
  • Kidney damage has been observed in one-third of COVID-19 patients studied in a new report
  • Remember that 5-minute rapid COVID test from Abbott? A study found that the test misses nearly half of positive cases.

Healthy Muse Visuals

In this week’s infographic post, we talk about Teladoc’s unprecedented growth – in both market capitalization and actual visit volumes – as a result of COVID-19. Click here to learn more.

Don’t call it a comeback – the return to Obamacare.

State Medicaid expansion? The WSJ reports that many GOP-led states are actually considering expanding Medicaid (paywall), something that would have been political taboo a short while ago.

  • It makes me wonder if these states will ask for block-grant funding – a new funding proposal Trump wants to try with Medicaid.

Insurers eye Obamacare: As individuals unfortunately lose jobs, many believe that the number of Medicaid enrollees will vastly increase.

State Budget problems: Despite the increase in unemployment and a public crisis, state officials are facing difficult budgeting decisions because of drastically lower tax revenue.

  • Many are considering cutting Medicaid budgets. In most states, Medicaid can comprise 20% or more of the budget, so it’s the first place officials look when it comes to cutting back on expenses.

So in summary: Some states are looking to expand Medicaid to increase federal $$$ to healthcare. Health insurance giants are getting back into ACA exchanges. Other states are planning to slash Medicaid budgets in a budget-balancing effort. Medicaid enrollees are expected to increase anywhere from 10 million to 23 million individuals over the next several months.

Relief fund problems.

This week, House Democrats proposed an additional $100 billion in emergency funding for providers.

  • While the bill is DOA in the Senate, that doesn’t mean that Phase 4 of the stimulus won’t provide more $$$ for providers.

Providers are growing increasingly concerned that the relief funds come with hidden strings attached – like quarterly reporting on where the money is going.

We’ve already seen providers speak cautiously about relief funds. Encompass Healthcare mentioned on its earnings calls that it had no plans to use the relief funds until the firm better understood the implications from HHS.

Other funding problems: Medicaid clinics and doctors have reported difficulties in getting relief funding. And a KHN analysis indicated that hospitals with higher levels of private insurance revenues are receiving a ‘disproportionately high share’ of total relief funding.

  • This makes sense, considering HHS’ methodology in distributing CARES Act funds: based on providers’ proportion of Medicare revenue for Round 1, then based on providers’ proportion of total net patient revenue for Round 2.
  • (Of course the hospitals with higher revenues will receive more funding – for now. Especially because private insurance reimburses providers at much higher rates than does Medicare. It’s not a secret.)



Quick Hits

Biz Hits

Other Hits

  • The FDA halted Bill Gates’ coronavirus testing program this week.
  • Anti-vaccine movement could undermine efforts to end coronavirus pandemic, researchers warn.
  • A KHN analysis estimates that 27 million Americans lost health insurance. About 80% of those have other options. Personally, I’m skeptical. The analysis doesn’t account for those who have been furloughed, are still on their employers’ health insurance plans, and are also eligible for unemployment benefits. The numbers will show the true fallout in the coming months.

Thought-Provoking Editorials




Thanks for reading.

Follow me on Twitter.

  • Save yourself some time by subscribing to our all-in-one newsletter. Subscribers get the first edition – every Monday night.

About the Healthy Muse.

The Healthy Muse was created to educate people on the healthcare system.

Get smarter and sign up below today.

more stuff

The mid-level takeover edition

This week in healthcare: UnitedHealthcare earnings, Carbon Connects with Froedert Health, NPs get full practice authority in New York, Bright Health is exiting 6 markets after a dismal 2021, public health emergency gets extended, and DaVita gets acquitted.

Why Inflation Destroys Provider Margins

If they aren’t already, providers are about to get killed by inflation. How do those dynamics affect healthcare provider organizations? How do healthcare services businesses stave off intense expense margin pressures while also increasing top-line revenue?

The Unstoppable Optum Edition

This week in healthcare: Breaking down the Intermountain merger with SCL Health, Optum continues its buying spree in purchasing Kelsey-Seybold, Hims & Hers partnership with Carbon Health, a 7 hospital health system merger in West Virginia, Aveanna’s bad Q4, CMS payment updates, Memorial Hermann’s urgent care JV with GoHealth, and lots of fundraising announcements.

Subscribe to take your healthcare knowledge to the next level.

Get breakdowns on the latest trends, and keep up with the healthcare stories that matter.